Ascentage Pharma Group International

Ascentage Pharma Group International is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company confirms in the following press release that they use animals for product testing.

Prof. Ruihua Xu commented, “Targeting PRC2 complex proteins, especially the EED, may be an effective mechanistic approach for treating cancer patients with certain genetic profiles. In both in vitro studies and in vivo studies in animal models, the EED inhibitor APG-5918 has shown clear targeted binding and target-based antitumor activity, thus warranting further clinical evaluations.” Read the article for more details